Literature DB >> 19574280

Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome.

Kari Sproul1, Michelle R Jones, Ricardo Azziz, Mark O Goodarzi.   

Abstract

OBJECTIVE: To examine the genes for AMP-activated protein kinase (AMPK) subunits alpha2 (PRKAA2) and gamma3 (PRKAG3) as candidates for polycystic ovary syndrome (PCOS) and its component traits. DESIGN AND METHODS: A total of 287 white PCOS women were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham and 187 white control subjects were recruited from the surrounding community. Seven PRKAA2 single nucleotide polymorphisms (SNPs) and four PRKAG3 SNPs were genotyped in PCOS cases and controls. Genotyping and association analysis were performed at Cedars-Sinai Medical Center.
RESULTS: Nominal associations of PRKAA2 variants with insulin-related traits and the PRKAG3 Pro71Ala variant with PCOS were not statistically significant after multiple testing correction. Among PCOS patients, there were no associations between variants in AMPK subunit genes and androgenic or reproductive traits.
CONCLUSIONS: Variants in genes for AMPKalpha2 and AMPKgamma3 were not associated with PCOS or its component traits. Our evidence does not demonstrate that AMPK is a major genetic risk factor for PCOS.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19574280      PMCID： PMC2754574          DOI： 10.1530/EJE-09-0245

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


  15 in total

1.  AMP-kinase alpha2 subunit gene PRKAA2 variants are associated with total cholesterol, low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol in normal women.

Authors:  N J Spencer-Jones; D Ge; H Snieder; U Perks; R Swaminathan; T D Spector; N D Carter; S D O'Dell
Journal:  J Med Genet       Date:  2006-06-26       Impact factor: 6.318

2.  Correct homeostasis model assessment (HOMA) evaluation uses the computer program.

Authors:  J C Levy; D R Matthews; M P Hermans
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

3.  Haplotype structures and large-scale association testing of the 5' AMP-activated protein kinase genes PRKAA2, PRKAB1, and PRKAB2 [corrected] with type 2 diabetes.

Authors:  Maria W Sun; Jennifer Y Lee; Paul I W de Bakker; Noël P Burtt; Peter Almgren; Lennart Råstam; Tiinamaija Tuomi; Daniel Gaudet; Mark J Daly; Joel N Hirschhorn; David Altshuler; Leif Groop; Jose C Florez
Journal:  Diabetes       Date:  2006-03       Impact factor: 9.461

4.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

Authors:  E Diamanti-Kandarakis; C R Kouli; A T Bergiele; F A Filandra; T C Tsianateli; G G Spina; E D Zapanti; M I Bartzis
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

5.  Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes.

Authors:  Parvaneh Keshavarz; Hiroshi Inoue; Naoto Nakamura; Toshikazu Yoshikawa; Toshihito Tanahashi; Mitsuo Itakura
Journal:  Mol Genet Metab       Date:  2007-10-18       Impact factor: 4.797

6.  Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome.

Authors:  Evanthia Diamanti-Kandarakis; Chryssa Kouli; Krystallenia Alexandraki; Giovanna Spina
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

7.  The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

Authors:  Benoit Viollet; Fabrizio Andreelli; Sebastian B Jørgensen; Christophe Perrin; Alain Geloen; Daisy Flamez; James Mu; Claudia Lenzner; Olivier Baud; Myriam Bennoun; Emmanuel Gomas; Gaël Nicolas; Jørgen F P Wojtaszewski; Axel Kahn; David Carling; Frans C Schuit; Morris J Birnbaum; Erik A Richter; Rémy Burcelin; Sophie Vaulont
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

8.  Role of AMP-activated protein kinase gamma 3 genetic variability in glucose and lipid metabolism in non-diabetic whites.

Authors:  P Weyrich; F Machicao; H Staiger; P Simon; C Thamer; J Machann; F Schick; A Guirguis; A Fritsche; N Stefan; H-U Häring
Journal:  Diabetologia       Date:  2007-08-14       Impact factor: 10.122

9.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

10.  Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.

Authors:  Nicolas Musi; Michael F Hirshman; Jonas Nygren; Monika Svanfeldt; Peter Bavenholm; Olav Rooyackers; Gaochao Zhou; Joanne M Williamson; Olle Ljunqvist; Suad Efendic; David E Moller; Anders Thorell; Laurie J Goodyear
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461
View more
  2 in total

1.  The SNF1 Kinase Ubiquitin-associated Domain Restrains Its Activation, Activity, and the Yeast Life Span.

Authors:  Rubin Jiao; Spike Postnikoff; Troy A Harkness; Terra G Arnason
Journal:  J Biol Chem       Date:  2015-04-13       Impact factor: 5.157

2.  Association of AMP-activated protein kinase with risk and progression of non-Hodgkin lymphoma.

Authors:  Aaron E Hoffman; Kathryn Demanelis; Alan Fu; Tongzhang Zheng; Yong Zhu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-08       Impact factor: 4.254
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.